Breaks Categories: Stock Spotlights

TuesdayNov 07, 2017 11:20 am

CBDNewsBreaks – PotNetwork Holding, Inc. (POTN) Strongly Positioned in a Market Projected to Reach $1.8B by 2020

PotNetwork Holding, Inc. (OTC: POTN) is positioned to profit from the continued growth in the cannabidiol (CBD) sector. Boasting an established product line and successful business model, the company and its Diamond CBD subsidiary stand out from competitors. An article discussing this reads: “The hemp-derived cannabidiol (CBD) market is projected to show phenomenal growth over the next few years. The Hemp Business Journal has projected a compound annual growth rate (CAGR) of 53 percent for CBD products derived from hemp, estimating this market to be worth $1.8 billion by 2020 (http://cnw.fm/mu4Ia). PotNetwork Holding, Inc. (OTC: POTN) is in a strong…

Continue Reading

MondayNov 06, 2017 12:03 pm

CBDNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen categories face lower regulatory burdens. Instead of pursuing full novel drug applications, which take anywhere from 7-9 years in clinical trials and cost hundreds of millions before securing FDA approval, IGC is developing cannabis-based drugs that could be commercialized in less than two years and…

Continue Reading

FridayNov 03, 2017 12:16 pm

CBDNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Unlocks Ability to Produce 90+ Cannabinoids through Biosynthesis

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinformatics database assessment tool. An article discussing this reads: “InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids (http://cnw.fm/hFe3o). The company recently announced it has enabled the production of all four “gateway” cannabinoids using genetically engineered microorganisms. From these gateway substrates, production of all 90+ cannabinoids is possible via biosynthesis. InMed’s breakthrough stands to make the production of cannabis derivatives, including THC, CBD…

Continue Reading

FridayNov 03, 2017 12:15 pm

CBDNewsBreaks – Skinvisible, Inc.’s (SKVI) Invisicare Technology Tackles Dermatology, CBD Markets

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has developed Invisicare® technology, a patented polymer delivery system that improves the delivery of topically applied skin care products by enhancing the effectiveness of the active ingredients. Skinvisible out-licenses its formulations, enabling companies like Canopy Hemp Corporation to bring their own patented products to market and combat generic competitors. An article discussing this reads: “With a $80 billion global dermatology market and a $30 billion global skin care over-the-counter (OTC) market, the patented polymer delivery system for topical products developed by Skinvisible, obviously, has many, many possible applications. The company has already…

Continue Reading

FridayNov 03, 2017 12:14 pm

CBDNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Targets Global Cannabis Market

As a licensed producer under the Marijuana for Medical Purposes Regulations in Canada, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) sells cannabis through its ABcann Medicinals, Inc. subsidiary. “We’re now, hopefully, going to be a global presence,” director Aaron Keay said in an interview with CannabisFN (CFN Media). An article discussing this reads: “ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) director Aaron Keay said in an interview with CannabisFN (CFN Media) that besides achieving greater market share in Canada, ABcann Global also sees opportunities for growth and presence in Western Europe, Germany and South America (http://cnw.fm/3uiqM). The company sells in…

Continue Reading

ThursdayNov 02, 2017 2:19 pm

CBDNewsBreaks – Grey Cloak Tech, Inc. (GRCK) Enters CBD Market through Strategic Acquisition

Grey Cloak Tech, Inc. (OTCQB: GRCK) recently entered the booming cannabis industry through the strategic acquisition of a medically-focused CBD company, Eqova Life Sciences. An article discussing this reads: “On October 24, 2017, Grey Cloak Tech, Inc. (OTCQB: GRCK) announced a 100 percent acquisition of Eqova Life Sciences – a renowned manufacturer of a wide range of hemp oil products. The company sent a letter of intent pertaining to the acquisition in September. Eqova, a company located in Denver, develops clinical-grade full spectrum hemp oil products, and it distributes via partnerships with licensed medical practitioners.” To view the full article,…

Continue Reading

ThursdayNov 02, 2017 2:19 pm

CBDNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, because Hyalolex does not need FDA approval. An article discussing this reads: “This hugely accelerated introduction of Hyalolex can only be accomplished in states where medical cannabis is legal and where the ailment (in this case Alzheimer’s) is an approved medical condition. In states where…

Continue Reading

WednesdayNov 01, 2017 12:22 pm

CBDNewsBreaks – Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery

Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company also aims to create a safe delivery method of cannabinoids and is currently working toward this goal with two universities in Canada. An article discussing this reads: “In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat…

Continue Reading

FridayOct 27, 2017 9:21 am

CBDNewsBreaks – Marijuana Company of America (MCOA) Delivers Distinctive Cannabis Investment Opportunities

Having now been legalized for medical and/or recreational use in 29 states and the District of Columbia, cannabis continues to represent an attractive market for investors, with both the legal marijuana and hemp industries marking notable increases. Marijuana Company of America (OTC: MCOA) is a distinctive corporation utilizing a strategic business structure within this burgeoning industry, uniting a diverse portfolio of investments and joint ventures beneath its umbrella that includes several companies involved in hemp cultivation and the development of optimum cultivation and processing facilities. “For companies like MCOA, the path forward is clear – participation in the legal cannabis…

Continue Reading

ThursdayOct 26, 2017 12:02 pm

CBDNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at the Global Skincare Market

Research and development company Skinvisible, Inc. (OTCQB: SKVI) has set its sights on the burgeoning global markets for skincare, dermatology and over-the-counter products. An article discussing this reads: “Skinvisible, Inc. (OTCQB: SKVI) is targeting a global skincare market that's projected to reach $135 billion by 2021 (http://cnw.fm/ud2WJ). SKVI also sees a worldwide dermatology market of $80 billion, plus a $30 billion worldwide over-the-counter (OTC) market (http://cnw.fm/noE7Y). It has already completed the development of 40 products, received numerous technology and product patents and is now ready to monetize its investment. In the U.S. alone, skincare is projected to reach $10.7 billion…

Continue Reading